These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 32822291)
21. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema. Cheong KX; Lee SY; Ang M; Teo KYC Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934 [TBL] [Abstract][Full Text] [Related]
22. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion. Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219 [TBL] [Abstract][Full Text] [Related]
23. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion. Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569 [TBL] [Abstract][Full Text] [Related]
24. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA. Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550 [TBL] [Abstract][Full Text] [Related]
25. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response. Lee J; Moon BG; Cho AR; Yoon YH Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201 [TBL] [Abstract][Full Text] [Related]
27. EVALUATION OF MACULAR ISCHEMIA IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. Ghashut R; Muraoka Y; Ooto S; Iida Y; Miwa Y; Suzuma K; Murakami T; Kadomoto S; Tsujikawa A; Yoshimura N Retina; 2018 Aug; 38(8):1571-1580. PubMed ID: 28671896 [TBL] [Abstract][Full Text] [Related]
28. OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept. Dastiridou A; Karathanou K; Riga P; Anagnostopoulou S; Balasubramanian S; Mataftsi A; Brazitikos P; Ziakas N; Androudi S Ocul Immunol Inflamm; 2021 Jul; 29(5):926-931. PubMed ID: 31951761 [No Abstract] [Full Text] [Related]
29. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept. Blindbæk SL; Peto T; Grauslund J Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608 [TBL] [Abstract][Full Text] [Related]
30. Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study. Babiuch A; Wykoff CC; Hach J; Srivastava S; Talcott KE; Yu HJ; Nittala M; Sadda S; Ip MS; Le T; Hu M; Reese J; Ehlers JP Br J Ophthalmol; 2021 Aug; 105(8):1111-1115. PubMed ID: 32829304 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the New "SAVE" Protocol in Diabetic Macular Edema Over the Course of Anti-VEGF Treatment. Reznicek L; Bolz M; Garip A; Kampik A; Kernt M; Mayer WJ Curr Eye Res; 2016 Aug; 41(8):1082-1086. PubMed ID: 26580417 [TBL] [Abstract][Full Text] [Related]
32. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Bahrami B; Hong T; Zhu M; Schlub TE; Chang A Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195 [TBL] [Abstract][Full Text] [Related]
33. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT. Ozsaygili C; Duru N Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970 [TBL] [Abstract][Full Text] [Related]
34. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion. Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457 [TBL] [Abstract][Full Text] [Related]
35. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies. Steinle NC; Du W; Gibson A; Saroj N Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314 [TBL] [Abstract][Full Text] [Related]
36. RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. Winegarner A; Wakabayashi T; Hara-Ueno C; Sato T; Busch C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K Retina; 2018 Oct; 38(10):2067-2072. PubMed ID: 28902097 [TBL] [Abstract][Full Text] [Related]
37. Classification of diabetic macular oedema using ultra-widefield angiography and implications for response to anti-VEGF therapy. Xue K; Yang E; Chong NV Br J Ophthalmol; 2017 May; 101(5):559-563. PubMed ID: 27531355 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of intravitreal ranibizumab and aflibercept on retinal vessel diameters in patients with diabetic macular edema. Aşikgarip N; Yenerel NM Photodiagnosis Photodyn Ther; 2021 Jun; 34():102282. PubMed ID: 33813015 [TBL] [Abstract][Full Text] [Related]
39. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415 [TBL] [Abstract][Full Text] [Related]